Estradiol and norethisterone transdermal patch - Johnson & Johnson
Alternative Names: Estradiol + norethisterone transdermal - Johnson & Johnson; Estradiol and norethisterone transdermal - Johnson & Johnson; Evorel Sequi; Systen SequiLatest Information Update: 11 Feb 2019
At a glance
- Originator Johnson & Johnson
- Developer Janssen-Cilag
- Class
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis